Home
Conditions
Refractory Acute Lymphoblastic Leukemia

Clinical trial condition

Refractory Acute Lymphoblastic Leukemia

Explore clinical trials studying Refractory Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

38 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Refractory Acute Lymphoblastic Leukemia trial results

Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

NCT03128034

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT03670966

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

NCT05418088

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT03263572

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

NCT03326921

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

NCT02392572

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

NCT06847269

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

NCT06316856

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China

Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China

The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China

View Trial Details

Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

NCT03136146

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Refractory Acute Lymphoblastic Leukemia

Refractory Acute Lymphoblastic Leukemia trial results

Related conditions